Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study

• Main Authors: Wang L., Heckman M.G., Aasly J.O., Annesi G., Bozi M., Chung S.J., Clarke C., Crosiers D., Eckstein G., Garraux G., Hadjigeorgiou G.M., Hattori N., Jeon B., Kim Y.J., Kubo M., Lesage S., Lin J.J., Lynch T., Lichtner P., Mellick G.D., Mok V., Morrison K.E., Quattrone A., Satake W., Silburn P.A., Stefanis L., Stockton J.D., Tan E.K., Toda T., Brice A., Van Broeckhoven C., Uitti R.J., Wirdefeldt K., Wszolek Z., Xiromerisiou G., Maraganore D.M., Gasser T., Krüger R., Farrer M.J., Ross O.A., Sharma M.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: Elsevier 2018
• Subjects: Genetic epidemiology; LRRK2; PARK16; Parkinson's disease
• Online Access: http://scholarbank.nus.edu.sg/handle/10635/150221
• Institution: National University of Singapore

10.1016/j.neurobiolaging.2016.09.022